Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659)

Author:

Gordon Leo I.1,Karmali Reem1,Kaplan Jason B.1,Popat Rakesh2,Burris Howard A.3,Ferrari Silvia4,Madan Sumit56,Patel Manish R.7,Gritti Giuseppe4,El-Sharkawi Dima28,Chau F. Ian9,Radford John10,de Oteyza Jaime Pérez11,Zinzani Pier Luigi1213,Iyer Swaminathan P.1415,Townsend William2,Miao Harry16,Proscurshim Igor16,Wang Shining16,Katyayan Shilpi1617,Yuan Ying16,Zhu Jiaxi16,Stumpo Kate16,Shou Yaping16,Carpio Cecilia18,Bosch Francesc1819

Affiliation:

1. Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center, Chicago, IL 60611, USA

2. Department of Haematology, NIHR/UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, UK

3. Drug Development, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN 37203, USA

4. Dipartimento di Oncologia ed Ematologia, Ospedale Papa Giovanni XXIII, Bergamo, Italy

5. Division of Hematology and Oncology, Cancer Therapy and Research Center at University of Texas Health Science Center, San Antonio, TX 78229, USA

6. Current affiliation: Division of Hematology and Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ 85234, USA

7. Drug Development Unit, Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL 34232, USA

8. Current affiliation: Department of Haematology, Royal Marsden Hospital, Sutton, Surrey, UK

9. Department of Medicine, Royal Marsden Hospital, Sutton, Surrey, UK

10. NIHR Clinical Research Facility, The Christie NHS Foundation Trust and University of Manchester, Manchester Academic Health Science Centre, Manchester, UK

11. Hematology, Hospital Universitario HM Sanchinarro, Madrid, Spain

12. IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy

13. Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy

14. Department of Hematology and Oncology, Houston Methodist Cancer Center, Houston, TX 77030, USA

15. Current affiliation: Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

16. Oncology Clinical Science, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA 02421, USA

17. Current affiliation: Biostatistics, Labcorp Drug Development, Princeton, NJ 08540, USA

18. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain

19. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3